4-O-Caffeoyl-3-O-syringoylquinic acidCAS# 1207645-17-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
Cas No. | 1207645-17-1 | SDF | Download SDF |
PubChem ID | N/A | Appearance | Powder |
Formula | C25H26O13 | M.Wt | 534.5 |
Type of Compound | Phenylpropanoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
4-O-Caffeoyl-3-O-syringoylquinic acid Dilution Calculator
4-O-Caffeoyl-3-O-syringoylquinic acid Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.8709 mL | 9.3545 mL | 18.7091 mL | 37.4181 mL | 46.7727 mL |
5 mM | 0.3742 mL | 1.8709 mL | 3.7418 mL | 7.4836 mL | 9.3545 mL |
10 mM | 0.1871 mL | 0.9355 mL | 1.8709 mL | 3.7418 mL | 4.6773 mL |
50 mM | 0.0374 mL | 0.1871 mL | 0.3742 mL | 0.7484 mL | 0.9355 mL |
100 mM | 0.0187 mL | 0.0935 mL | 0.1871 mL | 0.3742 mL | 0.4677 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 2,11,12-Trihydroxy-7,20-epoxy-8,11,13-abietatriene
Catalog No.:BCN0793
CAS No.:1608462-12-9
- 1,3,4,6-Tetragalloylglucose
Catalog No.:BCN0792
CAS No.:26922-99-6
- Norwogonin-8-O-glucuronide
Catalog No.:BCN0791
CAS No.:118525-47-6
- Narirutin 4'-glucoside
Catalog No.:BCN0790
CAS No.:17257-22-6
- 3-Hydroxymollugin
Catalog No.:BCN0789
CAS No.:154706-45-3
- Bergamjuicin
Catalog No.:BCN0788
CAS No.:2376307-20-7
- Citrusin C
Catalog No.:BCN0787
CAS No.:18604-50-7
- threo-Guaiacylglycerol-beta-coniferyl aldehyde ether
Catalog No.:BCN0786
CAS No.:650600-33-2
- Melitidin
Catalog No.:BCN0785
CAS No.:1162664-58-5
- Murracarpin
Catalog No.:BCN0784
CAS No.:120786-76-7
- Naringin 6''-acetate
Catalog No.:BCN0783
CAS No.:139934-60-4
- Erythro-Guaiacylglycerol-beta-coniferyl aldehyde ether
Catalog No.:BCN0782
CAS No.:74474-55-8
- Crepidiaside B
Catalog No.:BCN0795
CAS No.:101921-35-1
- Jacquilenin
Catalog No.:BCN0796
CAS No.:7726-34-3
- Umbelliferone 7-O-rutinoside
Catalog No.:BCN0797
CAS No.:135064-04-9
- Naringenin 7-O-gentiobioside
Catalog No.:BCN0798
CAS No.:104154-33-8
- 2-Phenylethyl-beta-glucopyranoside
Catalog No.:BCN0799
CAS No.:18997-54-1
- 11beta,13-Dihydrolactucin
Catalog No.:BCN0800
CAS No.:83117-63-9
- Cannabisin M
Catalog No.:BCN0801
CAS No.:1831134-13-4
- Epigambogellic acid
Catalog No.:BCN0802
CAS No.:1352191-85-5
- Moreollic acid
Catalog No.:BCN0803
CAS No.:173792-68-2
- Gambogoic acid A
Catalog No.:BCN0804
CAS No.:8879-23-49-1
- Roburin A
Catalog No.:BCN0805
CAS No.:132864-75-6
- Roburin B
Catalog No.:BCN0806
CAS No.:137370-65-1
Acyl quinic acid derivatives from the stems of Erycibe obtusifolia.[Pubmed:25256062]
Fitoterapia. 2014 Dec;99:109-16.
Eleven new acyl quinic acid derivatives, 4-O-Caffeoyl-3-O-syringoylquinic acid methyl ester (1), 4-O-caffeoyl-3-O-vanilloylquinic acid (2), 4-O-caffeoyl-3-O-vanilloylquinic acid methyl ester (3), 5-O-caffeoyl-3-O-vanilloylquinic acid (4), 5-O-caffeoyl-3-O-vanilloylquinic acid methyl ester (5), 5-O-caffeoyl-3-O-sinapoylquinic acid (6), 5-O-caffeoyl-4-O-vanilloylquinic acid (7), 4-O-(7'''S, 8'''R)-glycosmisoyl-5-O-caffeoylquinic acid methyl ester (8), 4-O-(7'''S, 8'''R)-glycosmisoyl-5-O-caffeoylquinic acid (9), 3-O-(7'''S, 8'''R)-glycosmisoyl-4-O-caffeoylquinic acid (10), and 3-O-(7'''S, 8'''R)-glycosmisoyl-4-O-caffeoylquinic acid methyl ester (11), have been isolated from the stems of Erycibe obtusifolia together with eight known compounds (12-19). Their structures were elucidated on the basis of spectroscopic data analysis (UV, IR, HRESIMS, CD, and 1D and 2D NMR) and chemical evidence. In in vitro assay, compounds 7 and 16-18 exhibited significant neuroprotective effects against rotenone induced PC12 cell damage at 10 muM.
Chemical constituents from the roots and stems of Erycibe obtusifolia and their in vitro antiviral activity.[Pubmed:24081686]
Planta Med. 2013 Nov;79(16):1558-64.
Three new quinic acid derivatives, 4-O-caffeoyl-3-O-sinapoylquinic acid methyl ester (1), 5-O-caffeoyl-4-O-syringoylquinic acid methyl ester (2), and 4-O-Caffeoyl-3-O-syringoylquinic acid methyl ester (3), as well as four new coumarin glycosides, 7-O-(3-O-sinapoyl-beta-D-glucopyranosyl)-6-methoxycoumarin (12), 7-O-(6-O-sinapoyl-beta-D-glucopyranosyl)-6-methoxycoumarin (13), 7-O-(2-O-sinapoyl-beta-D-glucopyranosyl)-6-methoxycoumarin (14), and 7-O-(6-O-syringoyl-beta-D-glucopyranosyl)-6-methoxycoumarin (15), together with eight known compounds (4-11) were isolated from the roots and stems of Erycibe obtusifolia. Their structures were elucidated on the basis of spectroscopic analysis and chemical evidence. All the compounds were screened for their in vitro antiviral activity against respiratory syncytial virus with a cytopathic effect reduction assay. Among them, the di-O-caffeoyl quinates 8-11 displayed a potent in vitro anti-respiratory syncytial virus effect.